title: 5-Hydroxytryptamine-1 receptor activation inhibits endocrine pancreatic secretion in humans.
abstract: The selective 5-hydroxytryptamine-1 receptor agonist sumatriptan inhibits exocrine pancreatic function in humans. No data are available on the effect of sumatriptan on fasting and postprandial endocrine pancreatic function in humans. To elucidate the influence of 5-hydroxytryptamine-1 receptor activation by sumatriptan on endocrine pancreatic function and blood glucose homeostasis, we determined plasma levels of somatostatin, glucagon, pancreatic polypeptide, insulin, and C-peptide before and after subcutaneous administration of sumatriptan (6 mg) in seven healthy volunteers, and we measured blood glucose and insulin plasma levels during an oral glucose tolerance test after placebo and after subcutaneous administration of sumatriptan (6 mg) in seven healthy volunteers. Sumatriptan significantly decreased the mean plasma levels of somatostatin, glucagon, pancreatic polypeptide, insulin and C-peptide (P < 0.001) and also significantly decreased mean and peak plasma levels of insulin after an oral glucose challenge (P < 0.02 and P = 0.04, respectively) without affecting glucose homeostasis. From our study, we speculate that activation of the 5-hydroxytryptamine-1 receptor inhibits endocrine pancreatic secretion.
authors.affiliation: Center for Gastroenterological Research, University Hospital Gasthuisberg, Catholic University of Leuven, Belgium.
authors.forename: B
authors.initials: B
authors.lastname: Coulie
authors.forename: J
authors.initials: J
authors.lastname: Tack
authors.forename: R
authors.initials: R
authors.lastname: Bouillon
authors.forename: T
authors.initials: T
authors.lastname: Peeters
authors.forename: J
authors.initials: J
authors.lastname: Janssens
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D005260:Female; D005934:Glucagon / Q000097:blood; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male; D010191:Pancreatic Polypeptide / Q000097:blood; D019518:Postprandial Period; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology*; D017366:Serotonin Receptor Agonists / Q000494:pharmacology; D013004:Somatostatin / Q000097:blood; D018170:Sumatriptan / Q000494:pharmacology
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists; D013004:Somatostatin; D010191:Pancreatic Polypeptide; D018170:Sumatriptan; D005934:Glucagon